RNA interference‑mediated knockdown of Aurora‑B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3‑kinase/Akt signaling pathway

Zhou,Long  Dian; Xiong,Xu; Long,Xin  Hua; Liu,Zhi  Li; Huang,Shan  Hu; Zhang,Wei

doi:10.3892/ol.2014.2464

RNA interference‑mediated knockdown of Aurora‑B alters the metastatic behavior of A549 cells via modulation of the phosphoinositide 3‑kinase/Akt signaling pathway

Authors:
- Long Dian Zhou
- Xu Xiong
- Xin Hua Long
- Zhi Li Liu
- Shan Hu Huang
- Wei Zhang
View Affiliations

Affiliations: Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 20, 2014 https://doi.org/10.3892/ol.2014.2464
Pages: 2063-2068

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Accumulating evidence has revealed that an elevated expression level of Aurora‑B is associated with metastasis in various types of malignant tumor. However, it is currently unclear whether this molecule is involved in non‑small lung cancer (NSCLC) metastasis, and the molecular mechanisms associated with Aurora‑B and metastasis remain unknown. In the present study, in order to investigate whether Aurora‑B is involved in the development and metastasis of NSCLC, the Aurora‑B protein expression in NSCLC tissues was detected by immunohistochemistry and its association with metastasis was analyzed. The results revealed that the expression levels of the Aurora‑B protein in tissues obtained from NSCLC patients with lymph node metastasis were significantly higher than those without metastatic disease. Furthermore, the effect of Aurora‑B inhibition on A549 cell migration and invasion, as well as the activity of the phosphoinositide 3‑kinase (PI3K)/Akt signaling pathway was evaluated. Aurora‑B was inhibited in the A549 cells using short hairpin RNA, and the cell migration and invasion rates were investigated using wound healing and Transwell invasion assays. In addition, the expression of the main proteins in the PI3K/Akt/nuclear factor‑κB (NF‑κB) signaling pathway, and matrix metalloproteinase (MMP)‑2 and ‑9 were measured by western blot analysis. The results demonstrated that cell migration and invasion were decreased as a result of silencing Aurora‑B. Furthermore, the activity of the PI3K/Akt/NF‑κB signaling pathway and the expression of MMP‑2 and ‑9 protein were suppressed by silencing Aurora‑B. The results of the present study indicate that the knockdown of Aurora‑B suppresses A549 cell invasion and migration via the inhibition of the PI3K/Akt signaling pathway in vitro and thus, targeting Aurora‑B may present a potential treatment strategy for NSCLC.

View Figures

View References

1	Shi L, Tang J, Tong L and Liu Z: Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials. Lung Cancer. 83:231–239. 2014.
2	Carmena M, Ruchaud S and Earnshaw WC: Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol. 21:796–805. 2009.
3	Ohi R, Sapra T, Howard J and Mitchison TJ: Differentiation of cytoplasmic and meiotic spindle assembly MCAK functions by Aurora B-dependent phosphorylation. Mol Biol Cell. 15:2895–2906. 2004.
4	Wang F, Ulyanova NP, Daum JR, Patnaik D, Kateneva AV, Gorbsky GJ and Higgins JM: Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation. J Cell Biol. 199:251–268. 2012.
5	Piekorz RP: Dissecting the role of INCENP-Aurora B in spindle assembly checkpoint function, chromosomal alignment and cytokinesis. Cell Cycle. 9:1678–1679. 2010.
6	Becker M, Stolz A, Ertych N and Bastians H: Centromere localization of INCENP-Aurora B is sufficient to support spindle checkpoint function. Cell Cycle. 9:1360–1372. 2010.
7	Li Y, Zhou W, Wei L, Jin J, Tang K, Li C, et al: The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma. Int J Oncol. 41:2139–2149. 2012.
8	Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BS, Shimamoto F, et al: Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch. 450:297–302. 2007.
9	Takeshita M, Koga T, Takayama K, Ijichi K, Yano T, Maehara Y, et al: Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer. Lung Cancer. 80:85–90. 2013.
10	Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, et al: Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Hum Pathol. 44:777–785. 2013.
11	Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, et al: Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. J Biol Chem. 287:29887–29998. 2012.
12	Tuncel H, Shimamoto F, Kaneko Guangying Qi H, Aoki E, Jikihara H, Nakai S, et al: Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncol Lett. 3:1109–1114. 2012.
13	Honma K, Nakanishi R, Nakanoko T, Ando K, Saeki H, Oki E, et al: Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers. Surg Today. 44:454–461. 2014.
14	Wang WR, Yang SS, Lin JX, Zeng ZY, Liu DM and Liu HT: Expression of Aurora-B in non-small cell lung cancer and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 29:1853–1856. 2009.(In Chinese).
15	Ma YX and Li XZ: Effect of aurora kinase B inhibitor AZD1152 in the treatment of cisplatin-resistant ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi. 48:46–50. 2013.(In Chinese).
16	Sak A, Stuschke M, Groneberg M, Kübler D, Pöttgen C and Eberhardt WE: Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines. Int J Radiat Oncol Biol Phys. 84:492–499. 2012.
17	Qi W, Liu X, Cooke LS, Persky DO, Miller TP, Squires M and Mahadevan D: AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. Int J Cancer. 130:2997–3005. 2012.
18	Zhang L and Zhang S: ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin. J Obstet Gynaecol Res. 37:591–600. 2011.
19	Pohl A, Azuma M, Zhang W, Yang D, Ning Y, Winder T, et al: Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer. Pharmacogenomics J. 11:93–99. 2011.
20	Lin ML, Lu YC, Chen HY, Lee CC, Chung JG and Chen SS: Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells. Mol Carcinog. 53:360–379. 2014.
21	Xu CL, Lu XL, Yan XN, Wang HL and Chen SQ: Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 47:134–138. 2012.(In Chinese).
22	Lin X, Zhang X, Wang Q, Li J, Zhang P, Zhao M and Li X: Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line. Neoplasma. 59:248–256. 2012.
23	Koumakpayi IH, Le Page C, Mes-Masson AM and Saad F: Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. Br J Cancer. 102:1163–1173. 2010.
24	Song L, Xiong H, Li J, Liao W, Wang L, Wu J and Li M: Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res. 17:1839–1849. 2011.
25	Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, et al: MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer. Cancer Lett. 286:206–216. 2009.
26	Long ZJ, Xu J, Yan M, Zhang JG, Guan Z, Xu DZ, et al: ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture. Cell Cycle. 7:1473–1479. 2008.
27	Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, et al: NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res. (Suppl 415): S75–S85. 2003.
28	Felx M, Guyot MC, Isler M, Turcotte RE, Doyon J, Khatib AM, et al: Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond). 110:645–654. 2006.